PLUS Based on the Value of the Worst Performing of the Nasdaq-100 Index® and the S&P 500® Index due January 31, 2030
Performance Leveraged Upside SecuritiesSM
Fully and Unconditionally Guaranteed by Morgan Stanley
Principal at Risk Securities
The PLUS are unsecured obligations of Morgan Stanley Finance LLC (“MSFL”) and are fully and unconditionally guaranteed by Morgan Stanley. The PLUS will pay no interest, do not guarantee any return of principal at maturity and have the terms described in the accompanying product supplement for PLUS, index supplement and prospectus, as supplemented or modified by this document. The payment at maturity on the PLUS will be based on the value of the worst performing of the Nasdaq-100 Index® and the S&P 500® Index, which we refer to as the underlying indices. At maturity, if both underlying indices have appreciated in value, investors will receive the stated principal amount of their investment plus leveraged upside performance of the worst performing underlying index. However, if the final index value of either underlying index is less than its respective initial index value, investors will lose some or all of their investment, resulting in a loss of 1% for every 1% decline in the worst performing underlying index from its initial index value. Investors may lose their entire initial investment in the PLUS. Because the payment at maturity of the PLUS is based on the worst performing of the underlying indices, a decline in either underlying index below its respective initial index value will result in a loss of your investment, even if the other underlying index has appreciated. These long-dated PLUS are for investors who seek an equity index-based return and who are willing to risk their principal, risk exposure to the worst performing of two underlying indices and forgo current income in exchange for the upside leverage feature that applies only if the final index value of each underlying index is greater than or equal to its respective initial index value. The PLUS are notes issued as part of MSFL’s Series A Global Medium-Term Notes program.
All payments are subject to our credit risk. If we default on our obligations, you could lose some or all of your investment. These PLUS are not secured obligations and you will not have any security interest in, or otherwise have any access to, any underlying reference asset or assets.
|
|
|
|
|
|
SUMMARY TERMS
|
Issuer:
|
Morgan Stanley Finance LLC
|
Guarantor:
|
Morgan Stanley
|
Maturity date:
|
January 31, 2030
|
Underlying indices:
|
Nasdaq-100 Index® (the “NDX Index”) and S&P 500® Index (the “SPX Index”)
|
Valuation date:
|
January 28, 2030, subject to postponement for non-index business days and certain market disruption events
|
Aggregate principal amount:
|
$
|
Payment at maturity:
|
If the final index value of each underlying index is greater than its respective initial index value,
$1,000 + leveraged upside payment
If the final index value of either underlying index is less than or equal to its respective initial index value:
$1,000 × index performance factor of the worst performing underlying index
Under these circumstances, the payment at maturity will be less than or equal to the stated principal amount of $1,000.
|
Leveraged upside payment:
|
$1,000 × leverage factor × index percent change of the worst performing underlying index
|
Leverage factor:
|
At least 134%. The actual leverage factor will be determined on the pricing date.
|
Index percent change:
|
With respect to each underlying index, (final index value – initial index value) / initial index value
|
Worst performing underlying index:
|
The underlying index with the lesser index percent change
|
Index performance factor
|
With respect to each underlying index, final index value / initial index value
|
Initial index value:
|
With respect to the NDX Index, , which is the index closing value of such index on the pricing date
With respect to the SPX Index, , which is the index closing value of such index on the pricing date
|
Final index value:
|
With respect to each underlying index, the index closing value of such index on the valuation date
|
Stated principal amount / Issue price:
|
$1,000 per PLUS (see “Commissions and issue price” below)
|
Pricing date:
|
January 28, 2025
|
Original issue date:
|
January 31, 2025 (3 business days after the pricing date)
|
CUSIP / ISIN:
|
61777RS79 / US61777RS799
|
Listing:
|
The PLUS will not be listed on any securities exchange.
|
Agent:
|
Morgan Stanley & Co. LLC (“MS & Co.”), an affiliate of MSFL and a wholly owned subsidiary of Morgan Stanley. See “Supplemental information regarding plan of distribution; conflicts of interest.”
|
Estimated value on the pricing date:
|
Approximately $963.90 per PLUS, or within $40.00 of that estimate. See “Investment Summary” beginning on page 2.
|
Commissions and issue price:
|
Price to public
|
Agent’s commissions(1)
|
Proceeds to us(2)
|
Per PLUS
|
$1,000
|
$
|
$
|
Total
|
$
|
$
|
$
|
(1)Selected dealers and their financial advisors will collectively receive from the agent, MS & Co., a fixed sales commission of $ for each PLUS they sell. See “Supplemental information regarding plan of distribution; conflicts of interest.” For additional information, see “Plan of Distribution (Conflicts of Interest)” in the accompanying product supplement.
(2)See “Use of proceeds and hedging” on page 16.
The PLUS involve risks not associated with an investment in ordinary debt securities. See “Risk Factors” beginning on page 6.
The Securities and Exchange Commission and state securities regulators have not approved or disapproved these securities, or determined if this document or the accompanying product supplement, index supplement and prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
The PLUS are not deposits or savings accounts and are not insured by the Federal Deposit Insurance Corporation or any other governmental agency or instrumentality, nor are they obligations of, or guaranteed by, a bank.
You should read this document together with the related product supplement, index supplement and prospectus, each of which can be accessed via the hyperlinks below. When you read the accompanying product supplement and index supplement, please note that all references in such supplements to the prospectus dated November 16, 2023, or to any sections therein, should refer instead to the accompanying prospectus dated April 12, 2024 or to the corresponding sections of such prospectus, as applicable. Please also see “Additional Terms of the PLUS” and “Additional Information About the PLUS” at the end of this document.
As used in this document, “we,” “us” and “our” refer to Morgan Stanley or MSFL, or Morgan Stanley and MSFL collectively, as the context requires.
Product Supplement for PLUS dated November 16, 2023 Index Supplement dated November 16, 2023 Prospectus dated April 12, 2024